BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26621338)

  • 1. Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus.
    Leich E; Hoster E; Wartenberg M; Unterhalt M; Siebert R; Koch K; Klapper W; Engelhard M; Puppe B; Horn H; Staiger AM; Stuhlmann-Laeisz C; Bernd HW; Feller AC; Hummel M; Lenze D; Stein H; Hartmann S; Hansmann ML; Möller P; Hiddemann W; Dreyling M; Ott G; Rosenwald A;
    Leukemia; 2016 Apr; 30(4):854-60. PubMed ID: 26621338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances.
    Guo Y; Karube K; Kawano R; Yamaguchi T; Suzumiya J; Huang GS; Ohshima K
    Leukemia; 2005 Jun; 19(6):1058-63. PubMed ID: 15815725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype.
    Leich E; Zamo A; Horn H; Haralambieva E; Puppe B; Gascoyne RD; Chan WC; Braziel RM; Rimsza LM; Weisenburger DD; Delabie J; Jaffe ES; Fitzgibbon J; Staudt LM; Mueller-Hermelink HK; Calaminici M; Campo E; Ott G; Hernández L; Rosenwald A
    Blood; 2011 Nov; 118(20):5550-8. PubMed ID: 21960592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
    Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
    Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of BCL2 breakpoints in follicular lymphoma and correlation with clinical features: specific subtypes or same disease?
    Buchonnet G; Jardin F; Jean N; Bertrand P; Parmentier F; Tison S; Lepretre S; Contentin N; Lenain P; Stamatoullas-Bastard A; Tilly H; Bastard C
    Leukemia; 2002 Sep; 16(9):1852-6. PubMed ID: 12200703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL6-translocations affect the phenotype of follicular lymphomas only in the absence of t(14;18)IgH/BCL2.
    Gollub W; Stassek B; Huckhagel T; Bernd HW; Krokowski M; Merz H; Feller AC; Thorns C
    Anticancer Res; 2009 Nov; 29(11):4649-55. PubMed ID: 20032416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translocation t(14;18)/IGH-BCL2 in gastrointestinal follicular lymphoma: correlation with clinicopathologic features in 48 patients.
    Yanai S; Nakamura S; Takeshita M; Fujita K; Hirahashi M; Kawasaki K; Kurahara K; Sakai Y; Matsumoto T
    Cancer; 2011 Jun; 117(11):2467-77. PubMed ID: 24048795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-"negative" grade 1/2 follicular lymphomas.
    Adam P; Baumann R; Schmidt J; Bettio S; Weisel K; Bonzheim I; Fend F; Quintanilla-Martínez L
    Hum Pathol; 2013 Sep; 44(9):1817-26. PubMed ID: 23642737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component.
    Katzenberger T; Ott G; Klein T; Kalla J; Müller-Hermelink HK; Ott MM
    Am J Pathol; 2004 Aug; 165(2):481-90. PubMed ID: 15277222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follicular lymphoma in Taiwan: a low frequency of t(14;18), with grade 3A tumours more closely related to grade 3B than to low-grade tumours.
    Chang ST; Lu YH; Lu CL; Kuo SY; Liu H; Lin SH; Win KT; Hsieh YC; Chuang SS
    Histopathology; 2013 Jul; 63(1):1-12. PubMed ID: 23631722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Cutaneous Follicle Center Lymphomas Expressing BCL2 Protein Frequently Harbor BCL2 Gene Break and May Present 1p36 Deletion: A Study of 20 Cases.
    Szablewski V; Ingen-Housz-Oro S; Baia M; Delfau-Larue MH; Copie-Bergman C; Ortonne N
    Am J Surg Pathol; 2016 Jan; 40(1):127-36. PubMed ID: 26658664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes.
    Vaandrager JW; Schuuring E; Raap T; Philippo K; Kleiverda K; Kluin P
    Genes Chromosomes Cancer; 2000 Jan; 27(1):85-94. PubMed ID: 10564590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrum of B-cell non-Hodgkin lymphomas with dual IgH-BCL2 and BCL6 translocations.
    Keller CE; Nandula S; Fisher J; Subramaniyam S; Vakiani E; Savage DG; Murty VV; Alobeid B; Bhagat G
    Am J Clin Pathol; 2008 Aug; 130(2):193-201. PubMed ID: 18628087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristics.
    Jardin F; Gaulard P; Buchonnet G; Contentin N; Leprêtre S; Lenain P; Stamatoullas A; Picquenot JM; Duval C; Parmentier F; Tilly H; Bastard C
    Leukemia; 2002 Nov; 16(11):2309-17. PubMed ID: 12399977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinicopathologic and molecular study of follicular lymphoma in Taiwan.
    Chuang SS; Hsieh PP; Lu CL; Wang YH; Fu TY; Tseng HH
    Clin Lymphoma Myeloma; 2006 Jan; 6(4):314-8. PubMed ID: 16507209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma.
    Barreca A; Martinengo C; Annaratone L; Righi L; Chiappella A; Ladetto M; Demurtas A; Chiusa L; Stacchini A; Crosetto N; van Oudenaarden A; Chiarle R
    Blood Cancer J; 2014 Oct; 4(10):e249. PubMed ID: 25303368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in BCL2 protein expression in follicular lymphomas without t(14;18) chromosomal translocations.
    Masir N; Jones M; Abdul-Rahman F; Florence CS; Mason DY
    Pathology; 2012 Apr; 44(3):228-33. PubMed ID: 22406486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma.
    Correia C; Schneider PA; Dai H; Dogan A; Maurer MJ; Church AK; Novak AJ; Feldman AL; Wu X; Ding H; Meng XW; Cerhan JR; Slager SL; Macon WR; Habermann TM; Karp JE; Gore SD; Kay NE; Jelinek DF; Witzig TE; Nowakowski GS; Kaufmann SH
    Blood; 2015 Jan; 125(4):658-67. PubMed ID: 25452615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations.
    Leich E; Salaverria I; Bea S; Zettl A; Wright G; Moreno V; Gascoyne RD; Chan WC; Braziel RM; Rimsza LM; Weisenburger DD; Delabie J; Jaffe ES; Lister A; Fitzgibbon J; Staudt LM; Hartmann EM; Mueller-Hermelink HK; Campo E; Ott G; Rosenwald A
    Blood; 2009 Jul; 114(4):826-34. PubMed ID: 19471018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl2-negative follicular lymphomas frequently have Bcl6 translocation and/or Bcl6 or p53 expression.
    Guo Y; Karube K; Kawano R; Suzumiya J; Takeshita M; Kikuchi M; Huang GS; Li Q; Ohshima K
    Pathol Int; 2007 Mar; 57(3):148-52. PubMed ID: 17295647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.